Details for New Drug Application (NDA): 021375
✉ Email this page to a colleague
NDA 021375 describes ALAVERT, which is a drug marketed by Fdn Consumer and is included in one NDA. It is available from one supplier. Additional details are available on the ALAVERT profile page.
The generic ingredient in ALAVERT is loratadine. There are thirty-nine drug master file entries for this compound. One hundred and fifty-five suppliers are listed for this compound. Additional details are available on the loratadine profile page.
The generic ingredient in ALAVERT is loratadine. There are thirty-nine drug master file entries for this compound. One hundred and fifty-five suppliers are listed for this compound. Additional details are available on the loratadine profile page.
Summary for 021375
| Tradename: | ALAVERT |
| Applicant: | Fdn Consumer |
| Ingredient: | loratadine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021375
Suppliers and Packaging for NDA: 021375
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ALAVERT | loratadine | TABLET, ORALLY DISINTEGRATING;ORAL | 021375 | NDA | Foundation Consumer Brands | 80070-110 | 80070-110-18 | 18 BLISTER PACK in 1 CARTON (80070-110-18) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| ALAVERT | loratadine | TABLET, ORALLY DISINTEGRATING;ORAL | 021375 | NDA | Foundation Consumer Brands | 80070-110 | 80070-110-60 | 60 BLISTER PACK in 1 CARTON (80070-110-60) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 10MG | ||||
| Approval Date: | Dec 19, 2002 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
